Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19.

Published in:

Microbial Cell Factories, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12934-024-02320-5

By:

• Valdez‑Cruz, Norma A.;
• Rosiles-Becerril, Diego;
• Martínez-Olivares, Constanza E.;
• García‑Hernández, Enrique;
• Cobos-Marín, Laura;
• Garzón, Daniel;
• López-Salas, Francisco E.;
• Zavala, Guadalupe;
• Luviano, Axel;
• Olvera, Alejandro;
• Alagón, Alejandro;
• Ramírez, Octavio T.;
• Trujillo‑Roldán, Mauricio A.

Publication type:

Article